Search research articles
Contact Us
Filters
Showing results (1281-1290 of 1,388) with videos related to
Page
of 139
Sort By:
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
JAMA Dermatology
|
March 6, 2024
Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis
Nour Kibbi, Joshua L Owen, Brandon Worley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Annals of Surgery
|
December 23, 2015
The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer
Craig A Harris, Michael J Solomon, Alexander G Heriot, et al.
Neurology
|
December 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial
Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, et al.
Endocrine
|
October 5, 2016
Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk
Adam Hulman, Rebecca K Simmons, Dorte Vistisen, et al.
Frontiers in Pediatrics
|
October 17, 2022
Outcomes of endovascular embolization for Vein of Galen malformations: An individual participant data meta-analysis
Cody Savage, Andrew T Hale, Matthew S Parr, et al.
JTO Clinical and Research Reports
|
September 23, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
Malinda Itchins, Shirley Liang, Chris Brown, et al.
The British Journal of Surgery
|
April 28, 2026
Presacral Tumours: an international consensus on diagnosis and management
William R G Perry, Kilian G M Brown, Elaine Burns, et al.
Page
of 139
Search research articles
Search
Showing results (1281-1290 of 1,388) with videos related to
Sort By:
Page
of 139
Cancer Research Communications
|
March 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, et al.
JAMA Dermatology
|
March 6, 2024
Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis
Nour Kibbi, Joshua L Owen, Brandon Worley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2013
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
S A Laurie, B J Solomon, L Seymour, et al.
Annals of Surgery
|
December 23, 2015
The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer
Craig A Harris, Michael J Solomon, Alexander G Heriot, et al.
Neurology
|
December 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial
Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 2019
<i>ALK</i> Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, et al.
Endocrine
|
October 5, 2016
Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk
Adam Hulman, Rebecca K Simmons, Dorte Vistisen, et al.
Frontiers in Pediatrics
|
October 17, 2022
Outcomes of endovascular embolization for Vein of Galen malformations: An individual participant data meta-analysis
Cody Savage, Andrew T Hale, Matthew S Parr, et al.
JTO Clinical and Research Reports
|
September 23, 2024
ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance
Malinda Itchins, Shirley Liang, Chris Brown, et al.
The British Journal of Surgery
|
April 28, 2026
Presacral Tumours: an international consensus on diagnosis and management
William R G Perry, Kilian G M Brown, Elaine Burns, et al.
Page
of 139